We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Abciximab vs Thrombectomy for Reperfusion in Myocardial Infarction

Wouter J. Kikkert, MD; Jose P. S. Henriques, MD, PhD
JAMA. 2012;308(6):565-567. doi:10.1001/jama.2012.8155.
Text Size: A A A
Published online


To the Editor: The study by Dr Stone and colleagues1 investigated the effect on infarct size of a pharmacological strategy, a mechanical strategy, or both aimed at improving myocardial perfusion at the tissue level. Distal embolization is considered to play a major role in poor myocardial perfusion at the tissue level and is associated with poor angiographic results, larger infarct size, and subsequent worse clinical outcomes after primary percutaneous coronary intervention (PCI).2 Previous studies have shown a beneficial effect of manual thrombectomy on markers of reperfusion and infarct size.3 The Thrombus Aspiration during Percutaneous Coronary Intervention in Acute Myocardial Infarction study (TAPAS) showed that manual thrombectomy resulted in better myocardial blush and ST-segment resolution.4 However, in the INFUSE-AMI study, manual thrombectomy was not associated with an improvement in these surrogate end points and subsequent smaller infarct size.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




August 8, 2012
Gregg W. Stone, MD; Sorin J. Brener, MD; C. Michael Gibson, MD
JAMA. 2012;308(6):565-567. doi:10.1001/jama.2012.8167.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.